• SENSEX 82,726.64
    539.83 (+0.66%)
  • BANKNIFTY 56,756.00
    -196.75 (--0.35%)
  • Oberoi Realty
    1,751.00 1,440.05(%)
  • Canara Bank
    106.35 78.58(%)
  • SpiceJet
    40.84 79.90(%)
  • Lodha Developers
    1,330.55 1,036.00(%)
  • Havells India
    1,549.05 1,360.05(%)
  • ICICI Bank
    1,489.95 1,482.00(%)
  • One 97
    1,090.00 1,063.00(%)
  • Bombay Dyeing
    190.85 256.25(%)
  • Ola Electric
    43.95 157.53(%)
  • Dixon Technolog.
    16,671.15 19,149.80(%)
  • Anthem Bioscienc
    765.00 752.50(%)
  • Eternal Ltd
    303.60 311.60(%)
  • Paradeep Phosph.
    205.60 193.15(%)
  • Pidilite Inds.
    2,900.75 2,620.15(%)
  • Reliance Industr
    1,426.90 1,551.00(%)
  • I R F C
    136.90 209.10(%)
  • St Bk of India
    825.00 895.30(%)
  • Waaree Energies
    3,199.00 3,740.75(%)
  • Jayaswal Neco
    43.10 55.34(%)
  • Tata Motors
    692.95 1,179.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Dishman Carbogen Amcis Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 67697.0
  • ISIN : INE385W01011
254.05 -3 (-1.11%)
  • As on 23 Jul 2025 (EOD)

  • Today’s Low

    252.00

  • Today’s High

    261.40

  • Open

    258.70

  • Perv Close

    256.90

  • 52W Low

    155.05

  • 52W High

    307.98

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    3,983.07

  • Div & Yield %

    0.00

  • Book Value(₹)

    257.07

  • Debt-Equity Ratio

    -1.11

  • AGM Date

    22-Jul-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.40

  • Mar.Cap (₹Cr.)

    3,983.07

  • RONW (%)

    -2.68

  • ROCE (%)

    -0.03

Score Board

  • Equity (₹ in Cr.)

    31.36

  • BV (₹)

    257.10

  • Sales( ₹ in Cr.)

    399.84

  • NP (in Cr.)

    -9.87

  • NP Var(%)

    87.0

  • Div%

    0.0

  • CPS (₹)

    3.50

  • EPS (₹)

    -0.60

  • Traded Value (₹ in Lakhs)

    3,995.62

  • 52 Week High

    307.98

  • 52 Week Low

    155.05

  • Price BSE

    255.0

  • Price NSE

    254.00

  • Market Capital( in Cr.)

    3,995.62

  • P/C Ratio

    72.30

  • P/E Ratio

    -405.10

  • Price Vs.BV

    -0.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 327.35 402.55 306.61 200.32 580.74 549.47
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 327.35 402.55 306.61 200.32 580.74 549.47
Other Income 63.05 52.16 60.39 66.15 69.55 71.68
Stock Adjustments -8.27 -8.00 7.70 -22.54 -19.96 34.80
Total Income 382.13 446.71 374.70 243.93 630.33 655.95
EXPENDITURE :            
Raw Materials 107.70 163.35 107.11 75.04 180.15 197.38
Power and Fuel Cost 28.71 33.07 24.83 12.78 35.27 31.44
Employee Cost 91.54 86.13 79.04 58.23 88.87 80.27
Other Manufacturing Expenses 27.94 31.21 22.57 18.95 26.56 28.71
Selling and Administration Expenses 42.46 52.54 46.03 28.90 42.84 48.65
Miscellaneous Expenses 16.98 22.49 2.21 43.20 13.51 4.03
Employee Benefit Expenses 91.54 86.13 79.04 58.23 88.87 80.27
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 315.33 388.79 281.79 237.10 387.20 390.48
Operating Profit 66.80 57.92 92.91 6.83 243.13 265.47
Interest 68.19 57.92 37.23 34.17 47.02 47.43
Gross Profit -1.39 0.00 55.68 -27.34 196.11 218.04
Depreciation 101.61 96.20 140.07 141.35 140.65 136.31
Profit Before Tax -103.00 -96.20 -84.39 -168.69 55.46 81.73
Current Tax 11.06 0.00 0.00 17.97 9.30 17.01
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -37.65 -37.33 -52.84 46.15 7.64 8.71
Reported Net Profit -76.41 -58.87 -31.55 -232.81 38.52 56.01
Extraordinary Items -1.08 -2.79 -0.79 2.52 -4.06 0.16
Adjusted Net Profit -75.33 -56.08 -30.76 -235.33 42.58 55.85
Adjustment below Net Profit -0.07 0.33 0.10 -0.51 -0.27 0.34
P & L Balance brought forward -234.45 -175.91 -144.47 88.85 53.83 -2.53
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 3.23 0.00
P & L Balance carried down -310.93 -234.45 -175.92 -144.47 88.85 53.82
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 10.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.20
Earnings Per Share-Unit Curr -4.87 -3.75 -2.01 -14.85 2.46 3.47
Earnings Per Share(Adj)-Unit Curr -4.87 -3.75 -2.01 -14.85 2.46 3.47
Book Value 258.46 262.39 269.88 298.13 305.66 303.12
Book Value(Adj)-Unit Curr 258.46 262.39 269.88 298.13 305.66 303.12

Shareholding Pattern

  • Promoter Group

    59.32%

  • Public Share Holding

    40.68%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 93,002,442 59.32 93,002,442 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,000 0.00 5,000 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 93,007,442 59.32 93,007,442 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 14,880,556 9.49 14,880,556 61
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,656,449 1.06 1,656,449 6
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 312,500 0.20 312,500 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 16,849,505 10.75 16,849,505 70
2] Non Institution
Bodies Corporate 3,191,838 2.04 3,191,838 282
Clearing Members 400 0.00 400 5
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,383,040 0.88 1,383,040 962
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,391,625 0.89 1,391,625 1,255
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 16,576,278 10.57 16,576,278 24
Individuals holding nominal share capital up to Rs. 1 lakh 23,108,491 14.74 23,107,796 48,118
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,190 0.00 1,190 2
Others 36,786 0.02 36,786 2
Sub Total 46,926,148 29.93 46,925,453 50,681
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 156,783,095 100.00 156,782,400 50,757

Company Background

Dishman Carbogen Amcis LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Dishman Carbogen Amcis Ltd
  • BSE Code : 67697.0
  • ISIN : INE385W01011

  • Incorporation Year

    2007

  • Registered Office

    Dishman Corporate House
    Iscon-Bopal Road Ambli, Ahmedabad,
    Gujarat-380058

  • Telephone

    91-2717-400102/124

  • FAX

  • Chairman

    Janmejay R Vyas

  • Managing Director

    Arpit J Vyas

  • Company Secretary

    Shrima Dave

  • Auditor

    T R Chadha & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Dishman Carbogen Amcis Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Dishman Carbogen 254.85 390.40 327.35 -404.52 0.00
Abbott India 34,192.50 6,684.73 6,409.15 51.37 44.95
Astrazeneca Phar 9,002.30 1,330.33 1,295.53 194.43 33.26
P & G Health Ltd 5,861.90 1,166.89 1,151.26 38.74 39.76
Glaxosmi. Pharma 3,098.40 3,866.05 3,723.49 57.11 58.72
Cipla 1,465.00 20,029.57 19,044.85 22.94 21.40
Amrutanjan Healt 699.55 437.58 421.23 39.79 20.84
Fermenta Biotec. 386.95 442.21 430.53 16.85 17.61
Guj. Themis Bio. 372.80 174.19 169.82 83.21 44.82
Bliss GVS Pharma 158.55 703.42 667.20 24.24 9.16
Ambalal Sarabhai 35.11 19.33 4.04 32.51 2.10